These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31568822)

  • 1. Reprogramming extracellular vesicles with engineered proteins.
    Shi X; Cheng Q; Zhang Y
    Methods; 2020 May; 177():95-102. PubMed ID: 31568822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapeutics and as a Drug Delivery Platform.
    Baek G; Choi H; Kim Y; Lee HC; Choi C
    Stem Cells Transl Med; 2019 Sep; 8(9):880-886. PubMed ID: 31045328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Tracking of Extracellular Vesicles in Mice Using Fusion Protein Comprising Lactadherin and Gaussia Luciferase.
    Takahashi Y; Nishikawa M; Takakura Y
    Methods Mol Biol; 2017; 1660():245-254. PubMed ID: 28828662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation, purification and engineering of extracellular vesicles and their biomedical applications.
    Gao J; Dong X; Wang Z
    Methods; 2020 May; 177():114-125. PubMed ID: 31790730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles (EVs): Comprehensive packages with promises and complications for clinical translation and commercialization.
    Kwon YJ
    Methods; 2020 May; 177():1. PubMed ID: 32145390
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in therapeutic engineered extracellular vesicles.
    Yao C; Zhang H; Wang C
    Nanoscale; 2024 Apr; 16(16):7825-7840. PubMed ID: 38533676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
    Sun Y; Sun F; Xu W; Qian H
    Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Extracellular Vesicles for Cancer Therapy.
    Zhang X; Zhang H; Gu J; Zhang J; Shi H; Qian H; Wang D; Xu W; Pan J; Santos HA
    Adv Mater; 2021 Apr; 33(14):e2005709. PubMed ID: 33644908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Use of Tumor Cell-Derived Extracellular Vesicles.
    Liu J; Ma J; Tang K; Huang B
    Methods Mol Biol; 2017; 1660():433-440. PubMed ID: 28828677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to surface engineering of extracellular vesicles.
    Richter M; Vader P; Fuhrmann G
    Adv Drug Deliv Rev; 2021 Jun; 173():416-426. PubMed ID: 33831479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles as biomarkers and therapeutic targets for cancer.
    Urabe F; Kosaka N; Ito K; Kimura T; Egawa S; Ochiya T
    Am J Physiol Cell Physiol; 2020 Jan; 318(1):C29-C39. PubMed ID: 31693397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications.
    Lee CS; Lee M; Na K; Hwang HS
    Mol Pharm; 2023 Nov; 20(11):5278-5311. PubMed ID: 37867343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake.
    French KC; Antonyak MA; Cerione RA
    Semin Cell Dev Biol; 2017 Jul; 67():48-55. PubMed ID: 28104520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering.
    Alharbi M; Lai A; Godbole N; Guanzon D; Nair S; Zuñiga F; Quinn A; Yang M; Wu SY; Salomon C
    Int J Cancer; 2024 Oct; 155(8):1510-1523. PubMed ID: 38848494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EVs and Bioengineering: From Cellular Products to Engineered Nanomachines.
    Villata S; Canta M; Cauda V
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach.
    Kooijmans SAA; Gitz-Francois JJJM; Schiffelers RM; Vader P
    Nanoscale; 2018 Feb; 10(5):2413-2426. PubMed ID: 29334397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.